Symbole | YTM % | Volume | Prix % | Coupon % | Date d'échéance | Montant en suspens | Valeur nominale | Montant min de la dénomination | Émetteur |
---|---|---|---|---|---|---|---|---|---|
BBMY4560589Celgene Corporation 4.35% 15-NOV-2047 | 7,10% | 8 K | 76,09% | 4,35% | 2047-11-15 | 13,57 M USD | 1 000,00 USD | 2 000,00 USD | Celgene Corp. |
7,06% | 0 | 58,80% | 2,55% | 2050-11-13 | 1,5 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
6,50% | 0 | 67,75% | 2,35% | 2040-11-13 | 750 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
6,41% | 0 | 72,43% | 3,90% | 2062-03-15 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
BBMY4036425Celgene Corporation 5.25% 15-AUG-2043 | 6,40% | 65 K | 90,24% | 5,25% | 2043-08-15 | 4,06 M USD | 1 000,00 USD | 2 000,00 USD | Celgene Corp. |
BBMY4124214Celgene Corporation 4.625% 15-MAY-2044 | 6,38% | 20 K | 84,86% | 4,63% | 2044-05-15 | 3,69 M USD | 1 000,00 USD | 2 000,00 USD | Celgene Corp. |
6,33% | 0 | 73,75% | 3,70% | 2052-03-15 | 2 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
BBMY4275603Celgene Corporation 5.0% 15-AUG-2045 | 6,24% | 348 K | 88,78% | 5,00% | 2045-08-15 | 15,71 M USD | 1 000,00 USD | 2 000,00 USD | Celgene Corp. |
6,21% | 3,13 M | 75,19% | 3,25% | 2042-08-01 | 500 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
BBMY4597874Celgene Corporation 4.55% 20-FEB-2048 | 6,19% | 20 K | 84,30% | 4,55% | 2048-02-20 | 37,2 M USD | 1 000,00 USD | 2 000,00 USD | Celgene Corp. |
6,10% | 0 | 78,71% | 3,55% | 2042-03-15 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
6,06% | 26 K | 111,00% | 6,88% | 2097-08-01 | 62,42 M USD | 1 000,00 USD | 1 000,00 USD | Bristol Myers Squibb Co. | |
6,04% | 400 K | 82,28% | 4,25% | 2049-10-26 | 3,75 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
BBMY3685700Celgene Corporation 5.7% 15-OCT-2040 | 5,98% | 290 K | 97,64% | 5,70% | 2040-10-15 | 2,3 M USD | 1 000,00 USD | 2 000,00 USD | Celgene Corp. |
5,96% | 1 M | 84,47% | 4,35% | 2047-11-15 | 1,24 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
5,92% | 230 K | 86,69% | 4,55% | 2048-02-20 | 1,24 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
5,86% | 0 | 87,76% | 4,50% | 2044-03-01 | 341,52 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
5,85% | 0 | 97,63% | 5,65% | 2064-02-22 | 1,75 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
5,82% | 15 K | 94,89% | 5,25% | 2043-08-15 | 218,37 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
5,75% | 1 M | 89,73% | 4,63% | 2044-05-15 | 744,72 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
5,69% | 0 | 98,42% | 5,55% | 2054-02-22 | 2,75 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
5,66% | 0 | 109,02% | 6,40% | 2063-11-15 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
5,63% | 1,05 M | 93,97% | 5,00% | 2045-08-15 | 741,72 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
5,61% | 10,78 M | 88,23% | 4,13% | 2039-06-15 | 2 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
5,56% | 0 | 107,65% | 6,25% | 2053-11-15 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
5,52% | 0 | 99,84% | 5,50% | 2044-02-22 | 500 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
5,37% | 1,7 M | 102,78% | 5,70% | 2040-10-15 | 151,01 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
5,24% | 0 | 104,63% | 5,88% | 2036-11-15 | 279,22 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
5,23% | 0 | 88,27% | 2,95% | 2032-03-15 | 1,75 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
5,21% | 30 K | 107,18% | 6,13% | 2038-05-01 | 219,25 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
5,12% | 0 | 100,47% | 5,20% | 2034-02-22 | 2,5 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
5,08% | 841 K | 83,91% | 1,45% | 2030-11-13 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
BBMY4597873Celgene Corporation 3.9% 20-FEB-2028 | 5,01% | 7 K | 97,10% | 3,90% | 2028-02-20 | 43,84 M USD | 1 000,00 USD | 2 000,00 USD | Celgene Corp. |
4,96% | 0 | 105,76% | 5,90% | 2033-11-15 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
4,81% | 0 | 101,36% | 5,10% | 2031-02-22 | 1,25 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
4,77% | 9,46 M | 95,00% | 3,40% | 2029-07-26 | 2,37 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
4,73% | 0 | 104,71% | 5,75% | 2031-02-01 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
4,69% | 30 K | 99,62% | 3,88% | 2025-08-15 | 228,73 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
BBMY4560450Celgene Corporation 3.45% 15-NOV-2027 | 4,68% | 280 K | 97,03% | 3,45% | 2027-11-15 | 16,55 M USD | 1 000,00 USD | 2 000,00 USD | Celgene Corp. |
4,65% | 0 | 100,83% | 4,90% | 2029-02-22 | 1,75 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
4,63% | 0 | 97,46% | 3,25% | 2027-02-27 | 512,28 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
4,59% | 28 K | 100,26% | 4,86% | 2026-02-20 | 500 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
4,58% | 0 | 91,64% | 1,13% | 2027-11-13 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
4,55% | 3,05 M | 97,36% | 0,75% | 2025-11-13 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
4,41% | 0 | 100,51% | 4,95% | 2026-02-20 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
4,40% | 0 | 100,91% | 4,90% | 2027-02-22 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
4,39% | 60 K | 97,71% | 3,45% | 2027-11-15 | 517,67 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
4,39% | 20 K | 103,87% | 6,80% | 2026-11-15 | 255,95 M USD | 1 000,00 USD | 1 000,00 USD | Bristol Myers Squibb Co. | |
4,38% | 725 K | 98,54% | 3,20% | 2026-06-15 | 1,74 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
4,34% | 2,62 M | 98,83% | 3,90% | 2028-02-20 | 1,45 B USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
3,41% | 0 | 87,44% | 1,75% | 2035-05-15 | 575 M EUR | 1 000,00 EUR | 100 000,00 EUR | Bristol Myers Squibb Co. | |
2,86% | 0 | 99,60% | 1,00% | 2025-05-15 | 575 M EUR | 1 000,00 EUR | 100 000,00 EUR | Bristol Myers Squibb Co. | |
2,47% | 0 | 130,24% | 4,25% | 2049-10-26 | 500 K USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
2,39% | 0 | 122,76% | 4,13% | 2039-06-15 | 4,4 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
2,35% | 0 | 141,76% | 5,00% | 2045-08-15 | 1 K USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
2,32% | 0 | 137,60% | 4,55% | 2048-02-20 | 9,5 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
2,27% | 0 | 104,25% | 3,20% | 2026-06-15 | 5,95 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
1,47% | 0 | 116,80% | 3,90% | 2028-02-20 | 6,07 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
1,33% | 0 | 116,69% | 3,40% | 2029-07-26 | 26,56 M USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. | |
1,28% | 0 | 114,77% | 3,45% | 2027-11-15 | 67 K USD | 1 000,00 USD | 2 000,00 USD | Bristol Myers Squibb Co. |